Debt to EBITDA ratio Analysis of Verona Pharma PLC - Deep Dive
Debt to EBITDA of VRNA
Dec-23-1.02Very Poor Debt to EBITDA | Dec-22-0.0002Very Poor Debt to EBITDA | Growth-665024.33% |
Debt to EBITDA Analysis of Verona Pharma PLC
Debt to EBITDA Ratio of VRNA drastically fell by -665024.33 % this year. |
Debt to EBITDA Ratio with value of -0.0002 was highest in Year Dec-22 in last Five Years. |
Debt to EBITDA Ratio with value of -1.02 was lowest in Year Dec-23 in last Five Years. |
Latest Debt to EBITDA Ratio with value of -1.02 is lower than Average Debt to EBITDA of -0.244 in last five years. |
Other Debt to EBITDA Related Info of VRNA that may interest you.
Verona Pharma PLC Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
VRNA | 12.07 | 11.48 | 5.14 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..Debt to EBITDA Related Ratios
CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
Low Stability Stock |
FY - Historical Debt to EBITDA of Verona Pharma PLC
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
Debt to EBITDA | -1.02 | -0.0002 | -0.101 | -0.084 | -0.0118 | 0 | 229.78 |
Change | -665024.33 % | 99.85 % | -19.73 % | -613.19 % | -340749.17 % | -100.00 % |
FY Chart of Debt to EBITDA of Verona Pharma PLC
Note : All Data Generated at the End of Trading Hours (EOD Data)